Bronnen ADHD
1. American Psychiatric Association (2000). Diagnostic and statistical manual of mental disorders [DSM-IV-TR]. Washington, DC: American Psychiatric Association.
2. Buitelaar, J. (2001). Discussies over aandachtstekort-hyperactiviteitstoornis (ADHD): feiten, meningen en emoties. Nederlands Tijdschrift voor Geneeskunde, 145(31): 1485-1489.
3. Kooij, J., Buitelaar, J., Van Tilburg, W. (1999). Voorstel voor diagnostiek en behandeling van aandachtstekortstoornis met hyperactiviteit (ADHD) op volwassen leeftijd. Tijdschrift voor Psychiatrie, 41(9): 349-358.
4. Gaub, M., Carlson, C. (1997). Gender differences in ADHD: a meta-analysis and critical review. Journal of the American Academy of Child & Adolescent Psychiatry, 36(8): 1036-1045.
5. Gershon, J (2002). A meta-analytic review of gender differences in ADHD. Journal of Attention Disorders, 5(3): 143-154.
6. Gezondheidsraad (2000). Diagnostiek en behandeling van ADHD. Den Haag: Gezondheidsraad.
7. Buitelaar, J., Kooij, J. (2000). Aandachtstekort-hyperactiviteitstoornis (ADHD); achtergronden, diagnostiek en behandeling. Nederlands Tijdschrift voor Geneeskunde, 144(36): 1716-1723.
8. Swanson, J., Sergeant, J., Taylor, E., Sonuga-Barke, E., Jensen, P., Cantwell, D. (1998). Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet, 351(9100): 429-433.
9. Verhulst, F., Van der Ende, J., Ferdinand, R., Kasius, M. (1997). The prevalence of DSM-III-R diagnoses in a national sample of Dutch adolescents. Archives of General Psychiatry, 54(4): 329-336.
10. Barkley, R., Fischer, M., Smallish, L., Fletcher, K. (2002). The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. Journal of Abnormal Psychology, 111(2): 279-289.
11. Verhulst, F., Van der Ende, J., Rietbergen, A. (1997). Ten-year time trends of psychopathology in Dutch children and adolescents: No evidence for strong trends. Acta Psychiatrica Scandinavica, 96(1): 7-13.
12. Kooij, J. (2002). ADHD bij volwassenen: inleiding in diagnostiek en behandeling. Lisse: Swets & Zeitlinger.
13. Ormel, J, Neeleman, J., Wiersma, D (2001). Determinanten van psychische ongezondheid; implicaties voor onderzoek en beleid. Tijdschrift voor Psychiatrie, 43(4): 245-257.
14. Doyle, A., Faraone, S. (2002). Familial links between attention deficit hyperactivity disorder, conduct disorder, and bipolar disorder. Current Psychiatry Reports, 4(2): 146-152.
15. Faraone, S., Doyle, A. (2001). The nature and heritability of attention-deficit/hyperactivity disorder. Child and Adolescent Psychiatric Clinics of North America, 10(2): 299-316,viii-ix.
16. Kuntsi, J., Stevenson, J. (2000). Hyperactivity in children: a focus on genetic research and psychological theories. Clinical Child and Family Psychology Review, 3(1): 1-23.
17. Thapar, A., Holmes, J., Poulton, K., Harrington, R. (1999). Genetic basis of attention deficit and hyperactivity. British Journal of Psychiatry, 174(2): 105-111.
18. Barkley, R. (1997). ADHD and the nature of self-control. New York: Guilford.
19. Castellanos, F., Lee, P., Sharp, W., Jeffries, N., Greenstein, D., Clasen, L., Blumenthal, J., James, R., Ebens, C., Walter, J., Zijdenbos, A., Evans, A., Giedd, J., Rapoport, J. (2002). Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA, 288(14): 1740-1748.
20. Castellanos, F., Giedd, J., Marsh, W., Hamburger, S., Vaituzis, A., Dickstein, D., Sarfatti, S., Vauss, Y., Snell, J., Lange, N., Kaysen, D., Krain, A., Ritchie, G., Rajapakse, J., Rapoport, J. (1996). Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder. Archives of General Psychiatry, 53(7): 607-616.
21. Zametkin, A., Nordahl, T., Gross, M., King, A., Semple, W., Rumsey, J., Hamburger, S., Cohen, R. (1990). Cerebral glucose metabolism in adults with hyperactivity of childhood onset. New England Journal of Medicine, 323(20): 1361-1366.
22. Rubia, K., Overmeyer, S., Taylor, E., Brammer, M., Williams, S., Simmons, A., Bullmore, E. (1999). Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional MRI. American Journal of Psychiatry, 156(6): 891-896.
23. Milberger, S., Biederman, J., Faraone, S., Jones, J. (1998). Further evidence of an association between maternal smoking during pregnancy and attention deficit hyperactivity disorder: findings from a high-risk sample of siblings. Journal of Clinical Child Psychology, 27(3): 352-358.
24. Fergusson, D., Woodward, L., Horwood, L. (1998). Maternal smoking during pregnancy and psychiatric adjustment in late adolescence. Archives of General Psychiatry, 55(8): 721-727.
25. Streissguth, A., Bookstein, F., Sampson, P., Barr, H. (1995). Attention: prenatal alcohol and continuities of vigilance and attentional problems from 4 through 14 years. Development & Psychopathology, 7(3): 419-446.
26. Whitaker, A., Van Rossem, R., Feldman, J., Schonfeld, I., Pinto-Martin, J., Tore, C., Shaffer, D., Paneth, N. (1997). Psychiatric outcomes in low-birth-weight children at age 6 years: relation to neonatal cranial ultrasound abnormalities. Archives of General Psychiatry, 54(9): 847-856.
27. Breslau, N., Brown, G., DelDotto, J., Kumar, S., Ezhuthachan, S., Andreski, P., Hufnagle, K. (1996). Psychiatric sequelae of low birth weight at 6 years of age. Journal of Abnormal Child Psychology, 24(3): 385-400.
28. Botting, N., Powls, A., Cooke, R., Marlow, N. (1997). Attention deficit hyperactivity disorders and other psychiatric outcomes in very low birthweight children at 12 years. Journal of Child Psychology and Psychiatry, 38(8): 931-941.
29. Taylor, E., Sandberg, S., Thorley, G., Giles, S. (1991). The epidemiology of childhood hyperactivity. New York: Oxford University Press.
30. Dekker, M., Koot, H. (2003). DSM-IV disorders in children with borderline to moderate intellectual disability. I: prevalence and impact. Journal of the American Academy of Child & Adolescent Psychiatry, 42(8): 915-922.
31. Pearson, D., Yaffee, L., Loveland, K., Lewis, K. (1996). Comparison of sustained and selective attention in children who have mental retardation with and without attention deficit hyperactivity disorder. American Journal on Mental Retardation, 100(6): 592-607.
32. Crijnen, A., Achenbach, T., Verhulst, F. (1999). Problems reported by parents of children in multiple cultures: the Child Behavior Checklist syndrome constructs. American Journal of Psychiatry, 156(4): 569-574.
33. Biederman, J., Milberger, S., Faraone, S., Kiely, K., Guite, J., Mick, E., Ablon, S., Warburton, R., Reed, E. (1995). Family-environment risk factors for attention-deficit hyperactivity disorder. A test of Rutter's indicators of adversity. Archives of General Psychiatry , 52(6): 464-470.
34. Woodward, L., Taylor, E., Dowdney, L. (1998). The parenting and family functioning of children with hyperactivity. Journal of Child Psychology and Psychiatry, 39(2): 161-169.
35. Keown, L., Woodward, L. (2002). Early parent-child relations and family functioning of preschool boys with pervasive hyperactivity. Journal of Abnormal Child Psychology, 30(6): 541-553.
36. Johnston, C., Mash, E. (2001). Families of children with attention-deficit/hyperactivity disorder: review and recommendations for future research. Clinical Child and Family Psychology Review, 4(3): 183-207.
37. Wolraich, M., Wilson, D., White, J. (1995). The effect of sugar on behavior or cognition in children. A meta-analysis. JAMA, 274(20): 1617-1621.
38. Doreleijers, T. (1998). De dokter en de zware jongen: over de behandeling van jongeren met psychiatrische stoornissen die misdrijven begaan. Medisch Contact, 53(17): 581-585.
39. Buitelaar, J. (2001). Geboren voor het kwaad? Feiten en misverstanden over de relatie tussen ADHD en criminaliteit. Neuropraxis, 5(6): 198-200.
40. Barkley, R. (2002). Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 63(Supplement 12): 10-15.
41. Hill, J., Schoener, E. (1996). Age-dependent decline of attention deficit hyperactivity disorder. American Journal of Psychiatry, 153(9): 1143-1146.
42. Barkley, R. (1998). Attention-deficit hyperactivity disorder. Scientific American, 279(3): 66-71.
43. Biederman, J., Faraone, S., Milberger, S., Curtis, S., Chen, L., Marrs, A., Ouellette, C., Moore, P., Spencer, T. (1996). Predictors of persistence and remission of ADHD into adolescence: results from a four-year prospective follow-up study. Journal of the American Academy of Child & Adolescent Psychiatry, 35(3): 343-351.
44. Biederman, J., Faraone, S., Milberger, S., Guite, J., Mick, E., Chen, L., Mennin, D., Marrs, A., Ouellette, C., Moore, P., Spencer, T., Norman, D., Wilens, T., Kraus, I., Perrin, J. (1996). A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Archives of General Psychiatry, 53(5): 437-446.
45. Angold, A., Costello, E., Erkanli, A. (1999). Comorbidity. Journal of Child Psychology and Psychiatry, 40(1): 57-87.
46. Pliszka, S. (2000). Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder. Child and Adolescent Psychiatric Clinics of North America, 9(3): 525-540,vii.
47. Milberger, S., Biederman, J., Faraone, S., Chen, L., Jones, J. (1997). ADHD is associated with early initiation of cigarette smoking in children and adolescents. Journal of the American Academy of Child & Adolescent Psychiatry, 36(1): 37-44.
48. Biederman, J., Wilens, T., Mick, E., Faraone, S., Weber, W., Curtis, S., Thornell, A., Pfister, K., Jetton, J., Soriano, J. (1997). Is ADHD a risk factor for psychoactive substance use disorders? Findings from a four-year prospective follow-up study. Journal of the American Academy of Child & Adolescent Psychiatry, 36(1): 21-29.
49. Kooij, J., Aeckerlin, L., Buitelaar, J. (2001). Functioneren, comorbiditeit en behandeling van 141 volwassenen met aandachtstekort-hyperactiviteitstoornis (ADHD) op een algemene polikliniek Psychiatrie. Nederlands Tijdschrift voor Geneeskunde, 145(31): 1498-1501.
50. Sawyer, M., Whaites, L., Rey, J., Hazell, P., Graetz, B., Baghurst, P. (2002). Health-related quality of life of children and adolescents with mental disorders. Journal of the American Academy of Child & Adolescent Psychiatry, 41(5): 530-537.
51. Mannuzza, S., Klein, R., Bessler, A., Malloy, P., Hynes, M. (1997). Educational and occupational outcome of hyperactive boys grown up. Journal of the American Academy of Child & Adolescent Psychiatry, 36(9): 1222-1227.
52. Chan, E., Zhan, C., Homer, C. (2002). Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey. Archives of Pediatrics & Adolescent Medicine, 156(5): 504-511.
53. Barkley, R. (2002). Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 63(Supplement 12): 10-15.
54. Guevara, J., Lozano, P., Wickizer, T., Mell, L., Gephart, H. (2001). Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics, 108(1): 71-78.
55. Leibson, C., Katusic, S., Barbaresi, W., Ransom, J., O'Brien, P. (2001). Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA, 285(1): 60-66.
56. Cuijpers, P., Bohlmeijer, E. (2001). Preventie van psychische problemen vanuit de Geestelijke Gezondheidszorg : de effecten van groepsgerichte interventies. Utrecht: Trimbos-instituut.
57. Cuijpers, P. (2001). De effectiviteit van preventie van psychische problemen bij kinderen en jeugdigen : een overzicht van groepsinterventies. Tijdschrift voor Gezondheidswetenschappen, 79(8): 486-494.
58. Boer, F., Buitelaar, J., Van Daalen, E. (1999). Richtlijn diagnostiek en behandeling ADHD (kinderen en adolescenten). Amsterdam: Boom.
59. Achenbach, T. (1991). Integrative guide to the 1991 CBCL/4-18, YSR, and TRF profiles. Burlington: University of Vermont, Department of Psychiatry.
60. Collett, B., Ohan, J., Myers, K. (2003). Ten-year review of rating scales. V: scales assessing attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 42(9): 1015-1037.
61. Conners, C. (1999). Conners Rating Scales-Revised. In: M.E. Maruish (red.). The use of psychological testing for treatment planning and outcomes assessment (2nd ed.), p. 467-495.
62. Bird, H., Gould, M., Staghezza, B. (1992). Aggregating data from multiple informants in child psychiatry epidemiological research. Journal of the American Academy of Child & Adolescent Psychiatry, 31(1): 78-85.
63. Pliszka, S., Carlson, C., Swanson, J. (1999). ADHD with comorbid disorders : clinical assessment and management. New York ; London: Guilford.
64. Jadad, A., Boyle, M., Cunningham, C., Kim, M., Schachar, R. (1999). Treatment of attention-deficit/hyperactivity disorder. Evidence Report/Technology Assessment (Summary), 11): i-341
65. Multimodal Treatment Study of Children with ADHD Cooperative Group (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Multimodal Treatment Study of Children with ADHD. Archives of General Psychiatry, 56(12): 1073-1086.
66. Swanson, J., Kraemer, H., Hinshaw, S., Arnold, L., Conners, C., Abikoff, H., Clevenger, W., Davies, M., Elliott, G., Greenhill, L., Hechtman, L., Hoza, B., Jensen, P., March, J., Newcorn, J., Owens, E., Pelham, W., Schiller, E., Severe, J., Simpson, S., Vitiello, B., Wells, K., Wigal, T., Wu, M. (2001). Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. Journal of the American Academy of Child & Adolescent Psychiatry, 40(2): 168-179.
67. Schachar, R., Jadad, A., Gauld, M., Boyle, M., Booker, L., Snider, A., Kim, M., Cunningham, C. (2002). Attention-deficit hyperactivity disorder: critical appraisal of extended treatment studies. Canadian Journal of Psychiatry, 47(4): 337-348.
68. Guevara, J., Stein, M. (2001). Evidence based management of attention deficit hyperactivity disorder. British Medical Journal, 323(7323): 1232-1235.
69. Wilens, T., Spencer, T., Biederman, J. (2002). A review of the pharmacotherapy of adults with attention-deficit/hyperactivity disorder. Journal of Attention Disorders, 5(4): 189-202.
70. Weiss, M., Murray, C. (2003). Assessment and management of attention-deficit hyperactivity disorder in adults. Canadian Medical Association Journal, 168(6): 715-722.
71. Kooij, J. (2002). ADHD bij volwassenen: inleiding in diagnostiek en behandeling. Lisse: Swets & Zeitlinger.
72. Faraone, S., Biederman, J., Roe, C. (2002). Comparative efficacy of Adderall and methylphenidate in attention-deficit/hyperactivity disorder: a meta-analysis. Journal of Clinical Psychopharmacology, 22(5): 468-473.
73. Faraone, S., Biederman, J. (2002). Efficacy of Adderall for Attention-Deficit/Hyperactivity Disorder: a meta-analysis. Journal of Attention Disorders, 6(2): 69-75.
74. Klassen, A., Miller, A., Raina, P., Lee, S., Olsen, L. (1999). Attention-deficit hyperactivity disorder in children and youth: a quantitative systematic review of the efficacy of different management strategies. Canadian Journal of Psychiatry, 44(10): 1007-1016.
75. Spencer, T., Biederman, J., Wilens, T., Harding, M., O'Donnell, D., Griffin, S. (1996). Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. Journal of the American Academy of Child & Adolescent Psychiatry, 35(4): 409-432.
76. Elia, J., Ambrosini, P., Rapoport, J. (1999). Treatment of attention-deficit-hyperactivity disorder. New England Journal of Medicine, 340(10): 780-788.
77. Schachter, H., Pham, B., King, J., Langford, S., Moher, D. (2001). How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. Canadian Medical Association Journal, 165(11): 1475-1488.
78. Wolraich, M. (2003). Annotation: The use of psychotropic medications in children: an American view. Journal of Child Psychology and Psychiatry, 44(2): 159-168.
79. Gilmore, A., Milne, R. (2001). Methylphenidate in children with hyperactivity: review and cost-utility analysis. Pharmacoepidemiology & Drug Safety, 10(2): 85-94.
80. Buitelaar, J., Van der Gaag, R., Swaab-Barneveld, H., Kuiper, M. (1995). Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 34(8): 1025-1032.
81. Spencer, T., Wilens, T., Biederman, J., Faraone, S., Ablon, J., Lapey, K. (1995). A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Archives of General Psychiatry, 52(6): 434-443.
82. Kooij, J., Burger, H., Boonstra, A., Van der Linden, P., Kalma, L., Buitelaar, J. (2003). Efficacy and safety of methylphenidate in 45 adults with attention-deficit/hyperactivity disorder (ADHD). A randomised placebo-controlled double-blind cross-over trial. Submitted.
83. Connor, D., Glatt, S., Lopez, I., Jackson, D., Melloni, R., Jr. (2002). Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. Journal of the American Academy of Child & Adolescent Psychiatry, 41(3): 253-261.
84. Greenhill, L., Ford, R. (2002). Childhood attention-deficit hyperactivity disorder: Pharmacological treatments. In: P.E. Nathan, J.M. Gorman (red.). A guide to treatments that work (2nd ed.), p. 25-55.
85. Psychosocial Paediatrics Committee (2002). The use of stimulant medication in the treatment of attention deficit hyperactivity disorder. Position statement of the Canadian Paediatric Society. Paediatrics and Child Health, 7(10): 693-696.
86. Barkley, R., McMurray, M., Edelbrock, C., Robbins, K. (1990). Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics, 86(2): 184-192.
87. Buitelaar, J., Van der Gaag, R., Swaab-Barneveld, H., Kuiper, M. (1996). Pindolol and methylphenidate in children with attention-deficit hyperactivity disorder. Clinical efficacy and side-effects. Journal of Child Psychology and Psychiatry, 37(5): 587-595.
88. Wilens, T., Faraone, S., Biederman, J., Gunawardene, S. (2003). Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics, 111(1): 179-185.
89. Connor, D., Fletcher, K., Swanson, J. (1999). A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry, 38(12): 1551-1559.
90. Wilens, T., Biederman, J., Prince, J., Spencer, T., Faraone, S., Warburton, R., Schleifer, D., Harding, M., Linehan, C., Geller, D. (1996). Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. American Journal of Psychiatry, 153(9): 1147-1153.
91. Brue, A., Oakland, T. (2002). Alternative treatments for attention-deficit/hyperactivity disorder: does evidence support their use? Alternative Therapies in Health and Medicine, 8(1): 68-4.
92. Feingold, B. (1985). Why your child is hyperactive. New York: Random House.
93. Psychosocial Paediatrics Committee (2002). The use of alternative therapies in treating children with attention deficit hyperactivity disorder. Posititon statement of the Canadian Paediatric Society. Paediatrics and Child Health, 7(10): 710-718.
94. Pelham, W., Jr., Wheeler, T., Chronis, A. (1998). Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. Journal of Clinical Child Psychology, 27(2): 190-205.
95. Hinshaw, S., Klein, R., Abikoff, H. (2002). Childhood attention-deficit hyperactivity disorder: nonpharmacological treatments and their combination with medication. In: P.E. Nathan, J.M. Gorman (red.). A guide to treatments that work, p. 3-23.
96. Multimodal Treatment Study of Children with ADHD Cooperative Group (1999). Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder. The Multimodal Treatment Study of Children with ADHD. Archives of General Psychiatry, 56(12): 1088-1096.
97. Swanson, J., Kraemer, H., Hinshaw, S., Arnold, L., Conners, C., Abikoff, H., Clevenger, W., Davies, M., Elliott, G., Greenhill, L., Hechtman, L., Hoza, B., Jensen, P., March, J., Newcorn, J., Owens, E., Pelham, W., Schiller, E., Severe, J., Simpson, S., Vitiello, B., Wells, K., Wigal, T., Wu, M. (2001). Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. Journal of the American Academy of Child & Adolescent Psychiatry, 40(2): 168-179.
98. NFGV (2003). ADHD bij kinderen en volwassenen: als chaos het leven beheerst [brochure]. Utrecht: Nationaal Fonds Geestelijke Volksgezondheid.
99. Trimbos-instituut (2002). ADHD bij volwassenen : informatie voor cliënten, familie en andere betrokkenen [brochure]. Utrecht: Trimbos-instituut.
100. Kooij, J. (2003). In gesprek over: ADHD bij volwassenen [brochure]. Utrecht: Nederlandse Vereniging voor Psychiatrie.
101. Gunning, W., Paternotte, A. (1997). In gesprek over: Als uw kind te druk is [brochure]. Utrecht: Nederlandse Vereniging voor Psychiatrie.
102. Graaf, de, R., Ten Have, M., Van Dorsselaer, S. (2010). NEMESIS-2: De psychische gezondheid van de Nederlandse bevolking. Opzet en eerste resultaten. Utrecht: Trimbos-instituut.
